BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Akeso's Ivonescimab sBLA Accepted by NMPA for First-Line Treatment of PD-L1 Positive NSCLC

Akeso (9926.HK) is delighted to announce that the supplemental biologics license application (sBLA) for its independently developed, world's first-in-class...

July 30, 2024 | News

FDA Accepts Telix's NDA for TLX007-CDx, Expanding PSMA-PET Imaging Access

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces that the United States (U.S.) Food and Drug Administration (FDA) has...

July 24, 2024 | News

Amgen and NSG BioLabs Extend Golden Ticket Partnership, Doubling Applicants and Awarding PairX Bio for Innovation in Cancer Treatment

The Amgen Golden Ticket Award, now in its third year, showcases Amgen's and NSG BioLabs' efforts to support high-growth startups in a nurturing ecosystem...

July 18, 2024 | News

ADM Korea to Submit IND for Niclosamide-Based Combination Therapy for Prostate Cancer

IND for clinical study for combination therapy with hormone therapy in prostate cancer patients to be submitted in August, 2024. Niclosamide-based metab...

July 12, 2024 | News

Thermo Fisher and NCI Join Forces to Accelerate Precision Medicine Trials for AML and MDS

To help accelerate research into new treatments for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS), Thermo Fisher Scientific Inc. (NYSE: T...

July 12, 2024 | News

Surfix Diagnostics, NKI, and CRCbioscreen Collaborate to Enhance Colorectal Cancer Screening

Surfix Diagnostics alongside the Netherlands Cancer Institute (NKI) and CRCbioscreen, announce a collaboration aimed at enhancing colorectal cancer (CRC) s...

July 10, 2024 | News

Immorna Biotherapeutics to Launch Phase 1/2 Study of Novel mRNA Therapeutic for Cancer

Immorna Biotherapeutics, Inc. (Immorna), a clinical stage biotechnology company developing both self-replicating and conventional mRNA-based therapeutics a...

July 09, 2024 | News

Hinova Pharmaceuticals Secures FDA Fast Track Designation for HP518 in Treating AR+ Triple-Negative Breast Cancer

Hinova Pharmaceuticals a leading biopharmaceutical company dedicated to developing innovative cancer therapies, today announced that the U.S. Food an...

July 08, 2024 | News

APPIS Innovator Program 2024 Winners Announced

The APPIS Innovator Program 2024 has concluded with an impressive showcase of 49 entries from 21 countries, each addressing critical barrie...

July 04, 2024 | News

Genoks and Velsera Partner to Transform Cancer Diagnostics and Treatment in Turkey

Genoks, a leading Turkish genomics healthcare company, and Velsera, a global healthcare technology company offering a universal software platform to connec...

July 01, 2024 | News

Sirnaomics Completes Phase I Clinical Study of STP707 for Pancreatic Cancer with Strong Safety Profile and Promising Disease Stability

Sirnaomics , a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced that the Group h...

July 01, 2024 | News

Advancing Cancer Care: The Promise and Potential of CAR-T Therapy

In an interaction with BioPharma APAC, Anuradha Rajapakse, Senior Director for Value & Access at Gilead and Kite Oncology, This discussion...

June 28, 2024 | Interaction

EU Approves HUTCHMED's FRUZAQLA® for Previously Treated Metastatic Colorectal Cancer

— Approval for previously treated metastatic colorectal cancer based on results from positive, global, Phase III FRESCO-2 Trial — — FRUZ...

June 24, 2024 | News

Juniper Biologics Expands Distribution Rights for Caris Life Sciences' Advanced Cancer Profiling Services to Middle East and Africa

Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare and pharmaceuticals company focused on commercialising novel therapies, h...

June 24, 2024 | News

Stay Connected